Your browser is no longer supported. Please, upgrade your browser.
Centene Corporation
IndexS&P 500 P/E17.79 EPS (ttm)3.60 Insider Own1.90% Shs Outstand579.51M Perf Week-6.19%
Market Cap37.94B Forward P/E12.14 EPS next Y5.27 Insider Trans-5.15% Shs Float569.24M Perf Month5.98%
Income2.03B PEG1.64 EPS next Q0.47 Inst Own95.10% Short Float1.62% Perf Quarter-2.84%
Sales101.69B P/S0.37 EPS this Y39.10% Inst Trans0.02% Short Ratio2.44 Perf Half Y-3.44%
Book/sh44.39 P/B1.44 EPS next Y5.63% ROA3.30% Target Price81.12 Perf Year-1.75%
Cash/sh23.10 P/C2.77 EPS next 5Y10.87% ROE9.30% 52W Range43.96 - 74.70 Perf YTD6.60%
Dividend- P/FCF37.64 EPS past 5Y23.10% ROI4.90% 52W High-14.34% Beta0.53
Dividend %- Quick Ratio1.30 Sales past 5Y35.10% Gross Margin18.50% 52W Low45.56% ATR1.99
Employees56600 Current Ratio1.30 Sales Q/Q53.30% Oper. Margin3.30% RSI (14)50.60 Volatility2.69% 2.86%
OptionableYes Debt/Eq0.65 EPS Q/Q327.10% Profit Margin2.00% Rel Volume1.09 Prev Close65.03
ShortableYes LT Debt/Eq0.65 EarningsOct 27 BMO Payout0.00% Avg Volume3.78M Price63.99
Recom1.70 SMA202.25% SMA500.13% SMA2000.45% Volume4,105,592 Change-1.60%
Jan-15-21Downgrade Jefferies Buy → Hold $75 → $72
Sep-22-20Downgrade Stephens Overweight → Equal-Weight
Jul-01-20Initiated SVB Leerink Outperform $78
Feb-05-20Upgrade JP Morgan Neutral → Overweight $88
Feb-03-20Resumed Evercore ISI Outperform $90
Jan-28-20Reiterated Bernstein Outperform $84 → $103
Jan-06-20Upgrade Wolfe Research Peer Perform → Outperform
Sep-12-19Initiated Deutsche Bank Buy
May-10-19Upgrade Citigroup Neutral → Buy $69
Jan-14-19Initiated Stephens Overweight $147
Oct-24-18Upgrade Leerink Partners Mkt Perform → Outperform
Jul-18-18Resumed Citigroup Neutral $147
Dec-18-17Reiterated Jefferies Buy $112 → $115
Sep-13-17Reiterated Leerink Partners Mkt Perform $78 → $90
Jun-07-17Initiated Morgan Stanley Overweight
May-22-17Downgrade JP Morgan Overweight → Neutral
Apr-05-17Initiated Deutsche Bank Buy $84
Mar-23-17Downgrade Citigroup Buy → Neutral
Feb-08-17Reiterated Barclays Overweight $75 → $79
Feb-07-17Resumed Cantor Fitzgerald Overweight $85
Jan-14-21 08:00AM  
Jan-12-21 04:56PM  
Jan-11-21 11:34PM  
Jan-07-21 12:06PM  
Jan-06-21 10:53AM  
Jan-05-21 11:55AM  
Jan-04-21 08:51PM  
Dec-31-20 04:01PM  
Dec-30-20 07:00AM  
Dec-26-20 02:06AM  
Dec-22-20 11:24AM  
Dec-18-20 08:46AM  
Dec-17-20 04:24PM  
Dec-16-20 05:57PM  
Dec-15-20 07:27AM  
Dec-11-20 12:33PM  
Dec-08-20 07:00AM  
Dec-07-20 09:03AM  
Dec-01-20 04:30PM  
Nov-30-20 06:00AM  
Nov-25-20 12:45PM  
Nov-23-20 07:00AM  
Nov-20-20 08:00AM  
Nov-19-20 07:00AM  
Nov-18-20 07:00AM  
Nov-16-20 04:44PM  
Nov-13-20 10:02AM  
Nov-12-20 10:38AM  
Nov-11-20 10:05AM  
Nov-09-20 07:00AM  
Nov-04-20 04:31PM  
Oct-30-20 03:01PM  
Oct-28-20 12:45PM  
Oct-27-20 09:30PM  
Oct-23-20 08:11AM  
Oct-22-20 11:50AM  
Oct-21-20 07:00AM  
Oct-20-20 12:31PM  
Oct-19-20 11:40AM  
Oct-15-20 10:30AM  
Oct-10-20 08:00AM  
Oct-09-20 07:24AM  
Oct-08-20 11:42AM  
Oct-07-20 08:40AM  
Oct-06-20 11:50AM  
Sep-29-20 11:55AM  
Sep-28-20 03:32PM  
Sep-25-20 11:51AM  
Sep-24-20 10:54AM  
Sep-23-20 06:07PM  
Sep-21-20 04:33PM  
Sep-17-20 08:00AM  
Sep-15-20 10:57AM  
Sep-14-20 07:00AM  
Sep-13-20 09:41AM  
Sep-11-20 07:00AM  
Sep-10-20 08:00AM  
Sep-02-20 08:53AM  
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs; staffing services; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. Centene Corporation has a collaboration with AT&T. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunter Jesse NEVP, M&A & Chief Strategy OfcrJan 08Sale70.0011,250787,500436,792Jan 12 07:04 PM
BURKHALTER BRANDYEVP, Chief Operating OfficerJan 06Sale67.008,000536,000379,399Jan 08 06:34 PM
Burdick Kenneth AEVP, Markets & ProductsNov 09Sale70.1635,0002,455,600803,386Nov 10 07:26 PM
Hunter Jesse NEVP, M&A & Chief Strategy OfcrNov 09Sale70.0022,5001,575,000378,029Nov 10 07:27 PM
NEIDORFF MICHAEL FChairman, President & CEONov 09Sale70.12300,00021,036,0006,287,732Nov 10 07:27 PM
BURKHALTER BRANDYEVP, Chief Operating OfficerNov 05Sale67.008,000536,000320,544Nov 06 05:10 PM
DITMORE ROBERT KDirectorNov 03Sale65.1133,3342,170,377660,010Nov 04 06:27 PM
Burdick Kenneth AEVP, Markets & ProductsNov 02Sale62.0235,0002,170,700838,386Nov 03 06:17 PM
AYALA ORLANDODirectorOct 29Sale61.008,890542,290142,162Oct 30 05:15 PM
Burdick Kenneth AEVP, Markets & ProductsOct 05Sale62.0035,0002,170,000873,386Oct 07 05:14 PM
Thompson Tommy GDirectorOct 01Sale58.361,50087,540160,896Oct 02 06:28 PM
Burdick Kenneth AEVP, Markets & ProductsAug 10Sale63.3335,0002,216,550908,341Aug 11 06:09 PM
Burdick Kenneth AEVP, Markets & ProductsJul 30Sale65.9835,0002,309,300943,341Jul 31 04:34 PM
DITMORE ROBERT KDirectorJul 30Sale65.3433,3332,177,978692,660Jul 31 04:35 PM
AYALA ORLANDODirectorJul 30Sale65.369,878645,626151,052Jul 31 04:35 PM
Thompson Tommy GDirectorJul 01Sale64.131,50096,195162,396Jul 02 06:43 PM
AYALA ORLANDODirectorJun 22Sale63.8730,0001,916,100160,930Jun 23 07:03 PM
GEPHARDT Richard ADirectorJun 19Sale65.2814,749962,81560,262Jun 23 07:02 PM
GEPHARDT Richard ADirectorJun 16Sale65.0210,401676,27375,011Jun 18 06:05 PM
Burdick Kenneth AEVP, Markets & ProductsJun 08Sale65.9335,0002,307,550978,341Jun 10 05:51 PM
DITMORE ROBERT KDirectorJun 08Sale65.3133,3332,176,978725,340Jun 10 05:52 PM
BURKHALTER BRANDYEVP, Chief Operating OfficerJun 08Sale67.008,000536,000330,782Jun 10 05:51 PM
ROBERTS JOHN RDirectorMay 18Sale70.0010,000700,00027,504May 20 07:12 PM
Burdick Kenneth AEVP, Markets & ProductsMay 11Sale67.0935,0002,348,1501,013,341May 12 06:13 PM
Burdick Kenneth AEVP, Markets & ProductsApr 30Sale66.3235,0002,321,2001,048,341May 01 06:18 PM
Schwaneke Jeffrey A.EVP, CFOApr 09Sale68.007,500510,000405,624Apr 10 06:45 PM
Burdick Kenneth AEVP, Markets & ProductsApr 08Sale64.3220,3141,306,5961,083,341Apr 09 05:53 PM
Burdick Kenneth AEVP, Markets & ProductsApr 07Sale62.2214,686913,7631,103,655Apr 09 05:53 PM
Thompson Tommy GDirectorApr 06Sale58.001,50087,000380,928Apr 08 05:58 PM
NEIDORFF MICHAEL FChairman, President & CEOMar 04Option Exercise28.5112,500356,3757,087,732Mar 04 04:00 PM
Thompson Tommy GDirectorMar 02Sale53.4250026,710381,851Mar 04 05:34 PM
Thompson Tommy GDirectorFeb 06Sale65.8150032,905382,351Feb 10 07:37 PM
DITMORE ROBERT KDirectorFeb 06Sale65.3130,0001,959,300754,673Feb 10 07:37 PM